Libra Infusions Limited

DSE:LIBRAINFU Stock Report

Market Cap: ৳1.8b

Libra Infusions Valuation

Is LIBRAINFU undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LIBRAINFU when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LIBRAINFU (BDT810.1) is trading above our estimate of fair value (BDT8.04)

Significantly Below Fair Value: LIBRAINFU is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for LIBRAINFU?

Other financial metrics that can be useful for relative valuation.

LIBRAINFU key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does LIBRAINFU's PB Ratio compare to its peers?

The above table shows the PB ratio for LIBRAINFU vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average20.8x
IBP Indo-Bangla Pharmaceuticals
1xn/a৳1.6b
AMBEEPHA Ambee Pharmaceuticals
80.3xn/a৳2.0b
SILVAPHL Silva Pharmaceuticals
0.9xn/a৳2.0b
SILCOPHL Silco Pharmaceuticals
1xn/a৳2.2b
LIBRAINFU Libra Infusions
n/an/a৳1.8b

Price-To-Book vs Peers: Insufficient data to calculate LIBRAINFU's Price-To-Book Ratio vs. peers for valuation analysis.


Price to Earnings Ratio vs Industry

How does LIBRAINFU's PE Ratio compare vs other companies in the Asian Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.6%
n/an/an/a
No. of CompaniesPB048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.6%
n/an/an/a
No more companies

Price-To-Book vs Industry: Insufficient data to calculate LIBRAINFU's Price-To-Book Ratio vs. industry for valuation analysis.


Price to Book Ratio vs Fair Ratio

What is LIBRAINFU's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LIBRAINFU PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ration/a
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate LIBRAINFU's Price-To-Book Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.